fiskaltrust Launches Portugal’s only Certified Fiscalisation Middleware and CashBox

10.3.2026 08:30:00 CET | news aktuell GmbH | Press release

Share

Integration Partners and Commercial Partners can now access the Portuguese market through fiskaltrust's POS System API, covering full AT (Autoridade Tributária e Aduaneira) compliance.

(Salzburg, Austria) fiskaltrust.eu, the European fintech company delivering Compliance-as-a-Service for point-of-sale systems, announced the launch of the only fully certified fiscalisation Middleware and CashBox for Portugal.

Through a single integration to fiskaltrust's POS System API, Integration Partners can now access the Portuguese market with full compliance coverage without building or maintaining any local fiscal infrastructure themselves.

fiskaltrust's certified Middleware and CashBox for Portugal handles the full compliance stack through the POS System API, the same interface used by Integration Partners across Austria, Germany, France, Italy, Spain, and Greece.

Payments Integration Through Viva.com

Every payment generates a fiscal event and fiskaltrust aligns payment and receipt data in real time. For Portugal, payment is available through Viva.com while fiskaltrust covers fiscalisation compliance. Integration Partners get payment and compliance in one place, with no need to build separate connections or reconcile data manually.

Other Payment Service Providers (PSP) looking to operate in Portugal can integrate with fiskaltrust's POS System API to connect their payment flows directly to a fully compliant fiscal layer.

For Commercial Partners and POS resellers considering Portugal, fiskaltrust's market entry provides a ready market entry foundation. fiskaltrust's certified Middleware and CashBox for Portugal are available now for commercial Partners and POS resellers. Explore the offering at fiskaltrust.eu/en-pt, access technical documentation at docs.fiskaltrust.eu, or reach out directly at sales@fiskaltrust.eu

Contacts

Images

About news aktuell GmbH

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release

Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye